There has been an increasing interest in the effects of cannabis when it comes to a medical aspect, with more and more research dedicated to the topic. So this leads to the question of whether cannabis can be another type of treatment for cancer.
According to oncologist Dr. Donald Abrams, cannabis alone cannot cure cancer. There have yet to be studies that would prove this claim true or not to reach a definitive conclusion. Even though this has yet to be determined, researchers have already seen that there may be some potential there, specifically in cannabinoids THC and CBD. Some pharmaceutical companies have tested cannabinoid medications on patients suffering from brain tumors, and while the results were promising, it was not as dramatic as they perhaps have hoped. Nevertheless, there are pros and cons to the claim that cannabinoids can be another type of cancer treatment.
Dr. Abrams, along with Professor Manuel Guzman of Complutense University of Madrid, published a piece to clear up any confusion regarding cannabinoids and cancer treatment. They addressed the growing number of those diagnosed with cancer becoming convinced that cannabis or high concentrations of CBD or THC oil can actually help cure the condition. They were convinced through testimonials found online. They have also mentioned that RSO or Rick Simpson Oil was often a recommended cannabis product to try in cancer treatment.
Cannabis alone cannot cure cancer, but it can help the patient manage the side-effects of chemotherapy, one of the main methods of cancer treatment among patients. There have been studies showing that cannabis can help manage nausea and lack of appetite felt by patients as well as pain management.
In other types of cancer treatment, the Daily Mail reports that gene-editing is becoming the next best type of treatment. Gene-editing is basically scientists genetically engineering healthy cells to discover and destroy tumors. Following human trials on three older patients, the researchers found that these modified T-cells are safe. These T-cells can kill cancer cells and can stay in the body for nine months.
While the results were a success, more research is needed when it comes to this method as well as trials in bigger groups to reach a definitive conclusion on whether or not it can be used as a cure for cancer.


RFK Jr. Faces Scrutiny Over David Geier’s HHS Role and Vaccine Review Work
Medicare to Cover GLP-1 Weight-Loss and Diabetes Drugs Starting July 1
The four types of dementia most people don’t know exist
US Plans Kenya Ebola Quarantine Facility Amid Congo Outbreak
RFK Jr. Spokesman Resigns Over Trump Administration’s Flavored E-Cigarette Policy
Daiichi Sankyo Stock Drops After Earnings Delay and Oncology Review
US Tightens Ebola Controls as Congo Outbreak Sparks Global Concern
Why the future of marijuana legalization remains hazy despite high public support
NIH Infectious Disease Leadership Shake-Up Raises Concerns Amid Ebola, Hantavirus Outbreaks
TrumpRx Expands Discount Drug Access With 600 Generic Medications
AstraZeneca Q1 2026 Earnings Surge on Strong Oncology and Rare Disease Drug Sales
Supreme Court Blocks 5th Circuit Ruling on Abortion Pill Access
Organon Stock Surges After Reports of $13 Billion Buyout Bid by Sun Pharma
CDC Expands Ebola Screening Efforts at U.S. Entry Points Amid Congo and Uganda Outbreak
Trump Reportedly Approves Plan to Remove FDA Commissioner Marty Makary Amid Growing Controversies
UNAIDS Urges U.S. to Reconsider South Africa HIV Funding Withdrawal
GSK Reportedly Nears $9 Billion Acquisition of Cancer Drug Developer Nuvalent 



